Relief

Relief Therapeutics to Participate in Industry and Investor Conferences in May

Retrieved on: 
Monday, May 9, 2022
SIX Swiss Exchange, COVID-19, EDT, Interest, File, RLF, Treasurer, Metabolism, Patient, Urea, Acer, FDA, Industry, Vasoactive intestinal peptide, OTCQB, APR, VIP, History, CEST, LinkedIn, Maple syrup urine disease, Conference, PDUFA, Therapy, Pharmaceutical industry, Relief

Geneva, Switzerland, May 9, 2022 RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the following industry and investor conferences in May.

Key Points: 
  • Geneva, Switzerland, May 9, 2022 RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the following industry and investor conferences in May.
  • Jack Weinstein, Chief Financial Officer and Treasurer of Relief will present a company overview on May 17 at 2:30 p.m. CEST, in Milan, Italy.
  • The Bioquity Europe one-on-one partnering platform enables partners and investors to schedule virtual meetings.
  • RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbol RLFTF.

Prem Rawat Foundation Expands Humanitarian Aid for Ukraine War Victims

Retrieved on: 
Thursday, May 5, 2022
Linda, People, Hope, COVID-19, Friends, Candid (organization), WCK, Water, Prem Rawat, Food, Partnership, TPRF, Refugee, Non-governmental organization, Lists of disasters, LOS, World Central Kitchen, Charity, Trauma, Cereal, Medicine, Convenience food, Pharmaceutical industry, Cesvi, Relief

LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- Thanks to an outpouring of generosity from supporters across the globe, The Prem Rawat Foundation (TPRF) recently increased the amount of food, water and other humanitarian aid it has been able to give those suffering from the war in Ukraine.

Key Points: 
  • Thanks to an outpouring of generosity from supporters, The Prem Rawat Foundation increased the amount of food, water and other humanitarian aid it has been able to provide for Ukraine war victims.
  • LOS ANGELES, May 5, 2022 /PRNewswire-PRWeb/ -- Thanks to an outpouring of generosity from supporters across the globe, The Prem Rawat Foundation (TPRF) recently increased the amount of food, water and other humanitarian aid it has been able to give those suffering from the war in Ukraine.
  • Prem Rawat and all of us at TPRF are deeply concerned about the humanitarian crisis unfolding in Ukraine.
  • "Thank you to everyone at The Prem Rawat Foundation for your generous support.

Stoli® Group to Release Limited-Edition Bottle in Support of the Ukrainian People

Retrieved on: 
Tuesday, April 19, 2022
Vodka, SC, List of national independence days, Restaurant, Wine, QR, HI, Food, World Central Kitchen, MA, History, Meal, Hope, WCK, City, Multimedia, MS, Life insurance, Stolichnaya, Relief

NEW YORK, April 19, 2022 /PRNewswire/ -- Today, Stoli® Group announced the release of a limited-edition bottle of Stoli® Vodka to benefit Ukraine. Proceeds from the bottle will be donated to World Central Kitchen (WCK), a non-profit organization founded by Chef José Andrés that provides fresh, nutritious meals to refugees fleeing Ukraine and those who are staying in cities impacted by the war.           

Key Points: 
  • NEW YORK, April 19, 2022 /PRNewswire/ -- Today, Stoli Group announced the release of a limited-edition bottle of Stoli Vodka to benefit Ukraine.
  • "As Ukrainians continue to suffer unimaginable losses, we are doing our small part to show unequivocal support," said Damian McKinney, Global CEO, Stoli Group.
  • "This Stoli Vodka bottle will not only provide financial resources to Ukraine but is also a symbol of solidarity."
  • Mainly known for the Stoli Vodka brand, Stoli Grouphas expanded to appeal to luxury on-premise and more sophisticated global consumers.

Prem Rawat Foundation Aids People Suffering from War in Ukraine

Retrieved on: 
Wednesday, March 23, 2022
Linda, People, World Central Kitchen, Friends, Charity, City, Lists of disasters, Refugee, Food, Trauma, Candid (organization), Hope, COVID-19, Non-governmental organization, Prem Rawat, Cesvi, Water, WCK, TPRF, Partnership, Pharmaceutical industry, Relief

LOS ANGELES, March 23, 2022 /PRNewswire-PRWeb/ -- Thanks to an outpouring of generosity from supporters across the globe, The Prem Rawat Foundation (TPRF) is helping supply food, water and other humanitarian aid to those suffering from the war in Ukraine.

Key Points: 
  • LOS ANGELES, March 23, 2022 /PRNewswire-PRWeb/ -- Thanks to an outpouring of generosity from supporters across the globe, The Prem Rawat Foundation (TPRF) is helping supply food, water and other humanitarian aid to those suffering from the war in Ukraine.
  • "Prem Rawat and all of us at TPRF are deeply concerned about the humanitarian crisis unfolding in Ukraine.
  • Friends of TPRF have offered exceptional support to provide critical aid for people suffering from this tragic war.
  • "Thank you to everyone at The Prem Rawat Foundation for your generous support.

Performance Food Group Company Announces $50,000 Donation to World Central Kitchen

Retrieved on: 
Wednesday, March 16, 2022
Trucking, Transport, Philanthropy, Restaurant, Bar, Food, Beverage, Logistics, Supply Chain Management, Other Philanthropy, Retail, Supply Chain Management, Performance Food Group, Solution, WCK, School, Lists of disasters, Food, Climate, World Central Kitchen, Meal, Corporation, PFG, Refugee, Pacific typhoon season, NYSE, Industry, Bottled water, Relief

Performance Food Group Company (PFG) (NYSE:PFGC) announced a $50,000 donation to World Central Kitchen (WCK) to help support the organizations efforts to provide meals to Ukrainian refugees who have fled the country.

Key Points: 
  • Performance Food Group Company (PFG) (NYSE:PFGC) announced a $50,000 donation to World Central Kitchen (WCK) to help support the organizations efforts to provide meals to Ukrainian refugees who have fled the country.
  • World Central Kitchen is grateful for PFGs support and belief in our mission.
  • Fighting food insecurity and working to strengthen communities have long been a part of PFGs corporate social responsibility focus.
  • Performance Food Group is an industry leader and one of the largest food and foodservice distribution companies in North America with more than 150 locations in the U.S. and parts of Canada.

Relief Secures $15 Million in Series A Funding to Help Consumers Combat the Credit Card Debt Crisis

Retrieved on: 
Friday, February 18, 2022
Kraft Group, CTO, CEO, Interplay, American Express, Entrepreneurship, Negotiation, Technology, Citigroup, Machine learning, Industry, COVID-19, GLOBE, Black, Financial services, Bank, Relief

Relief is a startup working to lift people out of crippling credit card debt by negotiating with credit card companies on their behalf.

Key Points: 
  • Relief is a startup working to lift people out of crippling credit card debt by negotiating with credit card companies on their behalf.
  • Relief's app seamlessly negotiates with debt providers after analyzing a user's personal finances and can cut credit card debt in half or more on behalf of the user - for free.
  • "We are thrilled to partner with Relief in their mission to help consumers with unsustainable debt.
  • Consumers can sign up for the Relief waitlist at www.relief.app and earn $40 toward paying off their credit card debt for each friend they invite.

EQS-News: Relief Therapeutics Expands Its Board of Directors with the Appointment of Michelle Lock

Retrieved on: 
Wednesday, February 2, 2022
CNS, Leadership, Commerce, Patient, Therapy, Liver disease, SIX Swiss Exchange, Hematology, NAPB, Phenylketonuria, Biotechnology, Hotel manager, Acer, Board of directors, Board, COVID-19, General manager, Pharma, OTCQB, International, Urea, PKU, Neuroscience, Maple syrup urine disease, Senior, Vasoactive intestinal peptide, VIP, Virology, BMS, Industry, Acceleron Pharma, Bristol Myers Squibb, CEDEP, History, Internal, American, RLF, Pharmaceutical industry, Relief

"Relief's suite of commercial stage biopharmaceuticals, along with an impressive product pipeline and highly focused growth strategy, was instrumental in my decision to join the company's Board," noted Ms.

Key Points: 
  • "Relief's suite of commercial stage biopharmaceuticals, along with an impressive product pipeline and highly focused growth strategy, was instrumental in my decision to join the company's Board," noted Ms.
  • "I am delighted to contribute my insights and experience to Relief to help management achieve its U.S. and international commercialization goals at this pivotal time in the company's history."
  • Lock earned a degree in Science/Nursing at Royal Melbourne University, Australia and studied General Management and Internal General Management at CEDEP, France.
  • RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY.

NRx Responds to Relief’s Allegations of January 14, 2022

Retrieved on: 
Friday, January 14, 2022
Research, Fifth Amendment, Biology, Biotechnology, SEC, NASDAQ, Novartis, Development, JD, Israel Institute for Biological Research, US Foods, Biomedical Advanced Research and Development Authority, MPH, Complaint, Association, Defamation, National, COVID-19, National Security Advisor (United States), FINRA, History, Company, Food, FDA, Supreme court, Patient, Dark Enlightenment, J&J, Imprisonment, Fast Track, ASPE, Relief, Human services, United States Army, BARDA, Breakthrough therapy, Health, Relief Therapeutics, Lilly, Letter, GLOBE, ISA, Goal, Doctor of Science, Life insurance, Pharmaceutical industry, Allergan, Teva, Pfizer, MD

RADNOR, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals(NASDAQ:NRXP), a clinical-stage biopharmaceutical company, responded to todays press release issued by Relief Therapeutics.

Key Points: 
  • RADNOR, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals(NASDAQ:NRXP), a clinical-stage biopharmaceutical company, responded to todays press release issued by Relief Therapeutics.
  • Relief has accused NRx and its CEO of issuing false and misleading statements about the past actions of Reliefs Board and Management.
  • At no time has NRx accused any member of Reliefs board of current or past criminal activity.
  • NRx Pharmaceuticals (NRx) draws upon more than 300 years of collective, scientific, and drug-development experience to bring improved health to patients.

EQS-News: Relief Therapeutics to Participate in Virtual Investor Conferences in January

Retrieved on: 
Wednesday, January 5, 2022
Treasurer, VIP, Therapy, COVID-19, Maple syrup urine disease, Urea, SIX Swiss Exchange, Patient, Vasoactive intestinal peptide, Conference, NAPB, History, RLF, LinkedIn, OTCQB, Acer, Interest, Pharmaceutical industry, Video game, Relief

Geneva, Switzerland, January 5, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the following virtual investor conferences in January.

Key Points: 
  • Geneva, Switzerland, January 5, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the following virtual investor conferences in January.
  • Jack Weinstein, Chief Financial Officer and Treasurer of Relief, will present a company overview at the conference.
  • Mr. Weinstein will present a corporate overview of Relief which can be viewed on demand throughout the conference.
  • RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY.

Lutris Pharma to Participate in Virtual Investor Conferences in January

Retrieved on: 
Tuesday, January 4, 2022
Relief, SynCo Bio Partners, TEL, Compliance, EGFR, Clinical trial, Toxicity, Growth factor, Quality of life, JPM, Interest, Conference, Radiation, Breast cancer, Patient, BIO, Pharmaceutical industry

TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced participation in the following virtual conferences in January:

Key Points: 
  • TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced participation in the following virtual conferences in January:
    January 10-13: H.C. Wainwright BioConnect Conference.
  • Ben Corn, M.D., Chief Medical Officer of Lutris Pharma, will present a company overview at the conference.
  • The on-demand presentation will be available for viewing beginning January 10, at 7:00 am ET.
  • Noa Shelach, Ph.D., Chief Executive Officer of Lutris Pharma, will participate in one-on-one meetings during the conference.